The results implicated that the three collateral-related proteins (IGF2, LYVE1, and THBS1) were prognostic for patients with AIS due to LVO, while PPBP showed no potential for outcome prediction (Table 4). This evidence concerns the gene LYVE1 and androgen insensitivity syndrome.